Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,816 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial.
Cho BC, Lee JS, Wu YL, Cicin I, Dols MC, Ahn MJ, Cuppens K, Veillon R, Nadal E, Dias JM, Martin C, Reck M, Garon EB, Felip E, Paz-Ares L, Mornex F, Vokes EE, Adjei AA, Robinson C, Sato M, Vugmeyster Y, Machl A, Audhuy F, Chaudhary S, Barlesi F. Cho BC, et al. Among authors: chaudhary s. J Thorac Oncol. 2023 Dec;18(12):1731-1742. doi: 10.1016/j.jtho.2023.08.018. Epub 2023 Aug 18. J Thorac Oncol. 2023. PMID: 37597750 Free article. Clinical Trial.
Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC.
Rolfo C, Greillier L, Veillon R, Badin F, Ghiringhelli F, Isambert N, Paulus A, Chaudhary SP, Vugmeyster Y, Sato M, Hiret S. Rolfo C, et al. Among authors: chaudhary sp. JTO Clin Res Rep. 2024 Oct 19;6(1):100748. doi: 10.1016/j.jtocrr.2024.100748. eCollection 2025 Jan. JTO Clin Res Rep. 2024. PMID: 39717667 Free PMC article.
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
Goyal L, Chaudhary SP, Kwak EL, Abrams TA, Carpenter AN, Wolpin BM, Wadlow RC, Allen JN, Heist R, McCleary NJ, Chan JA, Goessling W, Schrag D, Ng K, Enzinger PC, Ryan DP, Clark JW. Goyal L, et al. Invest New Drugs. 2020 Oct;38(5):1533-1539. doi: 10.1007/s10637-019-00889-y. Epub 2020 Jan 2. Invest New Drugs. 2020. PMID: 31898183 Clinical Trial.
Artificial intelligence-based cardiovascular/stroke risk stratification in women affected by autoimmune disorders: a narrative survey.
Tiwari E, Shrimankar D, Maindarkar M, Bhagawati M, Kaur J, Singh IM, Mantella L, Johri AM, Khanna NN, Singh R, Chaudhary S, Saba L, Al-Maini M, Anand V, Kitas G, Suri JS. Tiwari E, et al. Among authors: chaudhary s. Rheumatol Int. 2025 Jan 2;45(1):14. doi: 10.1007/s00296-024-05756-5. Rheumatol Int. 2025. PMID: 39745536 Review.
The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country.
Haque Pial R, Rai GK, Shrestha R, Das SK, Chapagain RH, Chaudhary S, Tamrakar D, Kanodia P, Thapa P, Vemula S, Gupta BP, Hill A, Kimathi D, Baiden R, Kim HS, Excler JL, Wartel TA, Sahastrabuddhe S, Saluja T. Haque Pial R, et al. Among authors: chaudhary s. Hum Vaccin Immunother. 2025 Dec;21(1):2441425. doi: 10.1080/21645515.2024.2441425. Epub 2024 Dec 26. Hum Vaccin Immunother. 2025. PMID: 39723535 Free article.
1,816 results